Skip to main content

Table 2 Characteristics of patients who have relapsed

From: Interim-treatment quantitative PET parameters predict progression and death among patients with hodgkin's disease

Age Sex Stage mid/pre tx MTV mid/pre tx iSUV Chemo Clinical outcome Survival
17 M III A 0 0 Stanford V Progressed at completion of chemo and RT Alive
12 F IV B 6 7 Stanford V Progressed at completion of chemo and RT Dead
75 M IV B 141 172 ABVD Dyspnea & fluid overload after cycle 4 of ABVD, h/o orthotopic heart transplant Dead
40 M III A 74 33 ABVD Expanding large axillary mass, chemo suspended for surgical excision Dead
56 M IV B 7 9 BEACOPP Died unexpectedly after 2 cycles chemo Dead
26 M III A 0 0 ABVD Evidence of disease recurrence on PET-CT but asymptomatic Alive